{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-000109","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2024-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.134331+00:00","generated_at":"2026-06-07T05:40:12.679752+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Microbot Medical raises $2.73M via warrant exercise inducement, issues new series E options","bullets":["Entered inducement letter to exercise 1,685,682 preferred investment options at reduced price of $1.62/share for $2.73M gross proceeds.","New series E preferred investment options issued at $1.50/share, exercisable immediately for 5.5 years.","Net proceeds to fund LIBERTY Robotic System development, commercialization, and working capital.","H.C. Wainwright acted as exclusive placement agent; received 7.0% cash fee and 84,284 placement agent options at $2.025.","Closing expected January 3, 2024; resale registration statement to be filed within 30 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-000109","json":"https://secwatch.observer/filing/0001493152-24-000109.json","markdown":"https://secwatch.observer/filing/0001493152-24-000109.md","text":"https://secwatch.observer/filing/0001493152-24-000109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315224000109/0001493152-24-000109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315224000109/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T05:40:12.679752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a2b5b44ebd377ebf954800eb282b45a61c3d2ceb","claim":"Microbot Medical Inc. entered into Inducement Letter with certain holders valued at approximately $2.73 million (effective 2023-12-29).","evidence_excerpt":"On December 29, 2023, Microbot Medical Inc., a Delaware corporation (the “Company”), entered into a preferred investment option exercise inducement offer letter (the “Inducement Letter”) with certain holders (the “Holders”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224000109/0001493152-24-000109-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain holders"},{"label":"Value","value":"approximately $2.73 million"},{"label":"Effective","value":"2023-12-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}